Safety, immunogenicity, and lot-to-lot consistency of a split-virion quadrivalent influenza vaccine in younger and older adults: A phase III randomized, double-blind clinical trial

• Main Authors: Sanie Sesay (Author), Jerzy Brzostek (Author), Ingo Meyer (Author), Yves Donazzolo (Author), Geert Leroux-Roels (Author), Régine Rouzier (Author), Béatrice Astruc (Author), Henryk Szymanski (Author), Nicole Toursarkissian (Author), Corinne Vandermeulen (Author), Edyta Kowalska (Author), Pierre Van Damme (Author), Camille Salamand (Author), Stephanie Pepin (Author)
• Format: Book
• Published: Taylor & Francis Group, 2018-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Here, we report a randomized multicenter phase III trial assessing the lot-to-lot consistency of the 2014-2015 Northern Hemisphere quadrivalent split-virion inactivated influenza vaccine (IIV4; Sanofi Pasteur) and comparing its immunogenicity and safety with that of trivalent inactivated influenza v...